As of March 31, 2020, the Company had cash of $850 and a working capital deficit
(current liabilities in excess of current assets) of $68,501,692. During the
three months ended March 31, 2020, the net loss available to common stockholders
was $126,955,829 and net cash used in operating activities was $109,352. These
conditions raise substantial doubt about the Company's ability to continue as a
going concern for one year from the issuance of the condensed consolidated
financial statements.



During the three months ended March 31, 2020, the Company received proceeds of $132,000 from the issuance of convertible notes. The Company does not have sufficient cash to fund operations for the next fiscal year.





The Company's primary source of operating funds since inception has been cash
proceeds from the public and private placements of the Company's securities,
including debt and equity securities, and proceeds from the exercise of warrants
and options. The Company has experienced net losses and negative cash flows from
operations since inception and expects these conditions to continue for the
foreseeable future. The Company's ability to continue its operations is
dependent upon its ability to obtain additional capital through public or
private equity offerings, debt financings or other sources; however, financing
may not be available to the Company on acceptable terms, or at all. The
Company's failure to raise capital as and when needed could have a negative
impact on its financial condition and its ability to pursue its business
strategy, and the Company may be forced to curtail or cease operations.



Management's plans regarding these matters encompass the following actions: 1)
obtain funding from new and current investors to alleviate the Company's working
capital deficiency; and 2) implement a plan to generate revenues. The Company's
continued existence is dependent upon its ability to translate its audience into
revenues. However, the outcome of management's plans cannot be determined with
any degree of certainty.



Accordingly, the accompanying condensed consolidated financial statements have
been prepared on a going concern basis, which contemplates the realization of
assets and satisfaction of liabilities in the normal course of business for one
year from the date the condensed consolidated financial statements are issued.
The carrying amounts of assets and liabilities presented in the condensed
consolidated financial statements do not necessarily purport to represent
realizable or settlement values. The condensed consolidated financial statements
do not include any adjustments that might result should the Company be unable to
continue as a going concern.



                                      -5-





In March 2020, the World Health Organization declared COVID-19 a global
pandemic. This contagious disease outbreak, which has continued to spread, and
any related adverse public health developments, has adversely affected
workforces, customers, economies, and financial markets globally, leading to an
economic downturn. It has also disrupted the normal operations of many
businesses, including ours. It is not possible for us to predict the duration or
magnitude of the adverse results of the outbreak of COVID-19 and its effects on
our business including our financial condition, liquidity, or results of
operations at this time. Management is actively monitoring the global situation
and its impact on the Company's financial condition, liquidity, operations,
customers, industry, and workforce. Given the daily evolution of the COVID-19
outbreak and the global responses to curb its spread, the Company is not able to
estimate the effects that the COVID-19 outbreak will have on its results of
operations, financial condition, or liquidity for fiscal year 2020. As of the
date of this Quarterly Report on Form 10-Q, the Company has experienced delays
in securing new customers and related revenues and the longer this pandemic
continues there may be additional impacts. Furthermore, the COVID-19 outbreak
has and may continue to impact the Company's ability to raise capital. Although
the Company cannot estimate the length or gravity of the impact of the COVID-19
outbreak at this time, if the pandemic continues, it may have a material adverse
effect on the Company's results of future operations, financial position,
liquidity, and capital resources, and those of the third parties on which the
Company relies in fiscal year 2020.



NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES





Principles of Consolidation


The condensed consolidated financial statements include the accounts of MassRoots, Inc. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.





Use of Estimates



The preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America ("U.S. GAAP") requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities, disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Significant estimates include stock-based
compensation, fair values relating to derivative liabilities, fair value of
payroll tax liabilities, deemed dividends and the valuation allowance related to
deferred tax assets. Actual results may differ from these estimates.



Fair Value of Financial Instruments

The Financial Accounting Standards Board ("FASB") Accounting Standards
Codification ("ASC") Subtopic 825-10, "Financial Instruments" ("ASC 825-10")
requires disclosure of the fair value of certain financial instruments. The
estimated fair value of certain financial instruments, including cash, accounts
payable and accrued liabilities are carried at historical cost basis, which
approximates their fair value because of the short-term maturity of these
instruments. All other significant financial assets, financial liabilities and
equity instruments of the Company are either recognized or disclosed in the
condensed consolidated financial statements together with other information
relevant for making a reasonable assessment of future cash flows, interest

rate
risk and credit risk.


The Company follows ASC 825-10, which permits entities to choose to measure many financial instruments and certain other items at fair value.





Cash



For purposes of the condensed consolidated statements of cash flows, the Company
considers highly liquid investments with an original maturity of three months or
less to be cash equivalents. As of March 31, 2020 and December 31, 2019, the
Company had no cash equivalents. The Company maintains its cash in banks insured
by the Federal Deposit Insurance Corporation in accounts that at times may be in
excess of the federally insured limit of $250,000 per bank. The Company
minimizes this risk by placing its cash deposits with major financial
institutions. At March 31, 2020 and December 31, 2019, the uninsured balances
amounted to $0.



                                      -6-





Property and Equipment



Property and equipment are stated at cost and depreciated using the
straight-line method over their estimated useful lives of three to five years.
Repair and maintenance costs are expensed as incurred. When retired or otherwise
disposed, the related carrying value and accumulated depreciation are removed
from the respective accounts and the net difference less any amount realized
from disposition, is reflected in earnings.



Accounts Receivable and Allowance for Doubtful Accounts





The Company monitors outstanding receivables based on factors surrounding the
credit risk of specific customers, historical trends, and other information. The
allowance for doubtful accounts is estimated based on an assessment of the
Company's ability to collect on customer accounts receivable. There is judgment
involved with estimating the allowance for doubtful accounts, and if the
financial condition of the Company's customers were to deteriorate, resulting in
their inability to make the required payments, the Company may be required to
record additional allowances or charges against revenues. The Company writes-off
accounts receivable against the allowance when it determines a balance is
uncollectible and no longer actively pursues its collection.



Revenue Recognition


The Company recognizes revenue when services are realized or realizable and earned less estimated future doubtful accounts.


The Company's revenues are accounted for under ASC Topic 606, "Revenue From
Contracts With Customers" ("ASC 606") and generally do not require significant
estimates or judgments based on the nature of the Company's revenue streams. The
sales prices are generally fixed at the point of sale and all consideration from
contracts is included in the transaction price. The Company's contracts do not
include multiple performance obligations or material variable consideration.



In accordance with ASC 606, the Company recognizes revenue to depict the
transfer of promised goods or services to customers in an amount that reflects
the consideration to which the Company expects to be entitled in exchange for
those goods or services. MassRoots recognizes revenue in accordance with that
core principle by applying the following:



(i) Identify the contract(s) with a customer;

(ii) Identify the performance obligation in the contract;

(iii) Determine the transaction price;

(iv) Allocate the transaction price to the performance obligations in the


      contract; and



(v) Recognize revenue when (or as) MassRoots satisfies a performance obligation.


The Company primarily generates revenue by charging businesses to advertise on
the Company's website and social media channels. In cases where clients enter
advertising contracts for an extended period of time, the Company only
recognizes revenue for services provided during that quarter and defers the
remaining unearned revenue to future periods.



Advertising



The Company charges the costs of advertising to expense as incurred. For the
three months ended March 31, 2020 and 2019, the Company charged to operations $0
and $27,208, respectively, as advertising expense.



                                      -7-





Stock-Based Compensation



Stock-based compensation expense is measured at the grant date fair value of the
award and is expensed over the requisite service period. For stock-based awards
to employees, non-employees and directors, the Company calculates the fair value
of the award on the date of grant using the Black-Scholes option pricing model.
Determining the fair value of stock-based awards at the grant date under this
model requires judgment, including estimating volatility, employee stock option
exercise behaviors and forfeiture rates. The assumptions used in calculating the
fair value of stock-based awards represent the Company's best estimates, but
these estimates involve inherent uncertainties and the application of management
judgment.



Income Taxes



The Company follows ASC Subtopic 740-10, "Income Taxes" ("ASC 740-10") for
recording the provision for income taxes. Deferred tax assets and liabilities
are computed based upon the difference between the financial statement and
income tax basis of assets and liabilities using the enacted marginal tax rate
applicable when the related asset or liability is expected to be realized or
settled. Deferred income tax expenses or benefits are based on the changes in
the asset or liability during each period.



If available evidence suggests that it is more likely than not that some portion
or all of the deferred tax assets will not be realized, a valuation allowance is
required to reduce the deferred tax assets to the amount that is more likely
than not to be realized. Future changes in such valuation allowance are included
in the provision for deferred income taxes in the period of change. Deferred
income taxes may arise from temporary differences resulting from income and
expense items reported for financial accounting and tax purposes in different
periods.



Convertible Instruments



U.S. GAAP requires companies to bifurcate conversion options from their host
instruments and account for them as freestanding derivative financial
instruments according to certain criteria. The criteria include circumstances in
which (a) the economic characteristics and risks of the embedded derivative
instrument are not clearly and closely related to the economic characteristics
and risks of the host contract, (b) the hybrid instrument that embodies both the
embedded derivative instrument and the host contract is not re-measured at fair
value under otherwise applicable generally accepted accounting principles with
changes in fair value reported in earnings as they occur, and (c) a separate
instrument with the same terms as the embedded derivative instrument would be
considered a derivative instrument. An exception to this rule is when the host
instrument is deemed to be conventional, as that term is described under ASC
480, "Distinguishing Liabilities From Equity."



When the Company has determined that the embedded conversion options should not
be bifurcated from their host instruments, the Company records, when necessary,
discounts to convertible notes for the intrinsic value of conversion options
embedded in debt instruments based upon the differences between the fair value
of the underlying common stock at the commitment date of the note transaction
and the effective conversion price embedded in the note. Debt discounts under
these arrangements are amortized over the term of the related debt to their
stated date of redemption using the effective interest method.



Deemed Dividends and Beneficial Conversion Features





The Company records, when necessary, deemed dividends for: (i) warrant price
protection, based on the difference between the fair value of the warrants
immediately before and after the repricing (inclusive of any full ratchet
provisions); (ii) the exchange of preferred shares for convertible notes, based
on the amount of the face value of the convertible notes in excess of the
carrying value of the preferred shares; and (iii) the settlement of warrant
provisions, based on the fair value of the common shares issued. The Company
also records, when necessary, a contingent beneficial conversion resulting from
price protection of the conversion price of Series A Preferred Stock, based on
the change in the intrinsic value of the conversion options embedded in such
preferred stock.



                                      -8-




Derivative Financial Instruments





The Company classifies as equity any contracts that: (i) require physical
settlement or net-share settlement; or (ii) provide the Company with a choice of
net-cash settlement or settlement in its own shares (physical settlement or
net-share settlement) providing that such contracts are indexed to the Company's
own stock. The Company classifies as assets or liabilities any contracts that:
(i) require net-cash settlement (including a requirement to net cash settle the
contract if an event occurs and if that event is outside the Company's control);
or (ii) gives the counterparty a choice of net-cash settlement or settlement in
shares (physical settlement or net-share settlement). The Company assesses
classification of its common stock purchase warrants and other freestanding
derivatives at each reporting date to determine whether a change in
classification between assets and liabilities is required.



The Company's freestanding derivatives consisted of warrants to purchase common
stock that were issued in connection with the issuance of debt and the sale of
common shares, and of embedded conversion options within convertible notes. The
Company evaluated these derivatives to assess their proper classification in the
balance sheet as of March 31, 2020 and December 31, 2019 using the applicable
classification criteria enumerated under ASC 815, "Derivatives and Hedging." The
Company determined that certain embedded conversion and/or exercise features did
not contain fixed settlement provisions. The convertible notes contained a
conversion feature such that the Company could not ensure it would have adequate
authorized shares to meet all possible conversion demands.



As such, the Company was required to record the derivatives which do not have
fixed settlement provisions as liabilities and mark to market all such
derivatives to fair value at the end of each reporting period. The Company also
records derivative liabilities for instruments, including convertible notes,
preferred stock, and warrants, in which the Company does not have sufficient
authorized shares to cover the conversion of these instruments into shares

of
common stock.



Long-Lived Assets



The Company reviews its property and equipment and any identifiable intangibles
for impairment whenever events or changes in circumstances indicate that the
carrying amount of an asset may not be recoverable. The test for impairment is
required to be performed by management at least annually. Recoverability of
assets to be held and used is measured by a comparison of the carrying amount of
an asset to the future undiscounted operating cash flow expected to be generated
by the asset. If such assets are considered to be impaired, the impairment to be
recognized is measured by the amount by which the carrying amount of the asset
exceeds the fair value of the asset. Long-lived assets to be disposed of are
reported at the lower of carrying amount or fair value less costs to sell.
Intangible assets are stated at cost and reviewed annually to examine any
impairments, usually assuming an estimated useful life of three to five years.
When retired or otherwise disposed, the related carrying value and accumulated
depreciation are removed from the respective accounts and the net difference
less any amount realized from disposition, is reflected in earnings.



Indefinite Lived Intangibles and Goodwill


The Company accounts for business combinations under the acquisition method of
accounting in accordance with ASC 805, "Business Combinations," where the total
purchase price is allocated to the tangible and identified intangible assets
acquired and liabilities assumed based on their estimated fair values. The
purchase price is allocated using the information currently available, and may
be adjusted, up to one year from acquisition date, after obtaining more
information regarding, among other things, asset valuations, liabilities assumed
and revisions to preliminary estimates. The purchase price in excess of the fair
value of the tangible and identified intangible assets acquired less liabilities
assumed is recognized as goodwill.



The Company tests for indefinite lived intangibles and goodwill impairment in
the fourth quarter of each year and whenever events or circumstances indicate
that the carrying amount of the asset exceeds its fair value and may not be

recoverable.



Segment Reporting



Operating segments are defined as components of an enterprise for which separate
financial information is available and evaluated regularly by the Chief
Executive Officer, or decision-making group, in deciding the method to allocate
resources and assess performance. The Company currently has one reportable
segment for financial reporting purposes, which represents the Company's core
business.



                                      -9-





Net Loss Per Common Share



Net loss per share is computed by dividing the net loss by the weighted average
number of shares of common stock outstanding during the period. Diluted earnings
per share, if presented, would include the dilution that would occur upon the
exercise or conversion of all potentially dilutive securities into common stock
using the "treasury stock" and/or "if converted" methods, as applicable.



Potentially dilutive securities outstanding at March 31, 2020 and 2019 were not
included in the computation of diluted net loss per share because the effects
would have been anti-dilutive. The convertible notes, options and warrants are
considered to be common stock equivalents and are only included in the
calculation of diluted earnings per common share when their effect is dilutive.



Potentially dilutive securities excluded from the computation of basic and diluted net loss per share are as follows:

March 31,           March 31,
                                                                     2020               2019

Common stock issuable upon conversion of convertible notes 21,729,616,410 11,531,315 Options to purchase common shares

                                    27,621,765        27,621,765
Warrants to purchase common shares                               17,161,927,276        72,160,002
Totals                                                           38,919,165,451       111,313,082




Reclassifications



Certain reclassifications have been made to the prior years' data to conform to
the current year presentation. These reclassifications had no effect on reported
income (losses).


Recent Accounting Pronouncements


In August 2020, the FASB issued ASU 2020-06, which simplifies the guidance on
accounting for convertible debt instruments by removing the separation models
for (1) convertible debt with a cash conversion feature and (2) convertible
instruments with a beneficial conversion feature. As a result, the Company will
not separately present in equity an embedded conversion feature in such debt.
Instead, we will account for a convertible debt instrument wholly as debt,
unless certain other conditions are met. We expect the elimination of these
models will reduce reported interest expense and increase reported net income
for the Company's convertible instruments falling under the scope of those
models before the adoption of ASU 2020-06. Also, ASU 2020-06 requires the
application of the if-converted method for calculating diluted earnings per
share and the treasury stock method will be no longer available. The provisions
of ASU 2020-06 are applicable for fiscal years beginning after December 15,
2021, with early adoption permitted no earlier than fiscal years beginning after
December 15, 2020. The Company is currently evaluating the impact of ASU 2020-06
on its consolidated financial statements.



In August 2018, the FASB issued Accounting Standards Update ("ASU") 2018-13,
"Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the
Disclosure Requirements for Fair Value Measurement"("ASU 2018-13"). ASU 2018-13
removes certain disclosure requirements, including the amount of and reasons for
transfers between Level 1 and Level 2 of the fair value hierarchy, the policy
for timing of transfers between levels, and the valuation processes for Level 3
fair value measurements. ASU 2018-13 also adds disclosure requirements,
including changes in unrealized gains and losses for the period included in
other comprehensive income for recurring Level 3 fair value measurements, and
the range and weighted average of significant unobservable inputs used to
develop Level 3 fair value measurements. The amendments on changes in unrealized
gains and losses, and the range and weighted average of significant unobservable
inputs used to develop Level 3 fair value measurements, should be applied
prospectively for only the most recent interim or annual period presented in the
initial fiscal year of adoption. All other amendments should be applied
retrospectively to all periods presented upon their effective date. ASU 2018-13
became effective for us on January 1, 2020. The adoption of this update did not
have a material impact on the Company's condensed consolidated financial
statements and related disclosures.



There are other various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to have a material impact on the Company's financial position, results of operations or cash flows.

NOTE 4 - PROPERTY AND EQUIPMENT





Property and equipment as of March 31, 2020 and December 31, 2019 is summarized
as follows:



                                March 31,       December 31,
                                   2020             2019
Computers                       $    6,366     $        6,366
Office equipment                    17,621             17,621
Subtotal                            23,987             23,987
Less accumulated depreciation      (23,987 )          (23,987 )
Property and equipment, net     $        -     $            -



Depreciation expense for the three months ended March 31, 2020 and 2019 was $0 and $1,183, respectively.



                                      -10-




NOTE 5 - ADVANCES AND NON-CONVERTIBLE NOTES PAYABLE


During the three months ended March 31, 2020 and 2019, the Company received
aggregate proceeds from advances of $0 and $140,000 and repaid an aggregate of
$0 and $0, respectively, of advances. The advances were primarily for Simple
Agreements for Future Tokens, entered into with eight accredited investors
issued pursuant to an exemption from the registration requirements of the
Securities Act of 1933, as amended, by virtue of Section 4(a)(2) thereof
and/or Regulation D thereunder in 2017 and 2018. As of March 31, 2020 and
December 31, 2019, the Company owed $337,500 and $337,500 in principal and
$10,500 and $10,500 in accrued interest, respectively.



During the three months ended March 31, 2020 and 2019, the Company did not
receive any proceeds from the issuance of non-convertible notes and repaid an
aggregate of $21,750 and $0, respectively, of non-convertible notes. The
non-convertible notes have maturity dates ranging from March 21, 2019 to
September 15, 2019 and accrue interest at rates ranging from 0%-36% per annum.
As of March 31, 2020 and December 31, 2019, the Company owed $149,000 and
$165,750 in principal and $194,735 and $158,143 in accrued interest,
respectively.



NOTE 6 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES





As of March 31, 2020 and December 31, 2019, the Company owed accounts payable
and accrued expenses of $6,200,147 and $5,455,063, respectively. These are
primarily comprised of payments to vendors, accrued interest on debt and accrued
legal bills.


NOTE 7 - ACCRUED PAYROLL AND RELATED EXPENSES


The Company is delinquent in filing its payroll taxes, primarily related to
stock compensation awards in 2016 and 2017, but also including payroll for 2018
and 2019. At March 31, 2020 and December 31, 2019, the Company owed payroll tax
liabilities, including penalties, of $3,773,064 and $3,724,050, respectively, to
federal and state taxing authorities. The actual liability may be higher or
lower due to interest or penalties assessed by federal and state taxing
authorities. The Company expects to settle these liabilities by December 31,
2020.


NOTE 8 - COMMITMENTS AND CONTINGENCIES


In the ordinary course of business, the Company is occasionally involved in
lawsuits incidental to its business, including litigation related to its
convertible notes. Although it is difficult to predict the ultimate outcome of
these cases, management believes that any ultimate liability would not have a
material adverse effect on the Company's condensed consolidated financial
condition or results of operations. However, any unforeseen unfavorable
development in any of these cases could have a material adverse effect on the
Company's condensed consolidated financial condition. The Company records the
potential effects on operations or cash flows in the period in which such
effects are probable and reasonably estimable.



On October 11, 2019, Power Up Lending Group, Ltd. ("Power Up") filed a complaint
against the Company and Isaac Dietrich, an officer and director of the Company,
in the Supreme Court of the State of New York, County of Nassau. The complaint
alleges, among other things, (i) the occurrence of events of default in certain
notes (the "Power Up Notes") issued by the Company to Power Up, (ii)
misrepresentations by the Company including, but not limited to, with respect to
the Company's obligation to timely file its required reports with the SEC and
(iii) lost profits as a result of the Company's failure to convert the Power Up
Notes in accordance with the terms thereof. In addition, the complaint alleges,
among other things, that Mr. Dietrich took affirmative steps to deliberately
cause the Company to breach its financial obligations. As a result of the
foregoing, Power Up has requested (i) the greater of $312,000 and the "parity
value" as such term is defined in the Power Up Notes together with $2,000 per
day until the Company issues shares upon conversion of the Power Up Notes
together with applicable interest thereon; (ii) $165,000 as a result of the
misrepresentations; (iii) an amount of lost profits to be determined by the
court, but in no event less than $312,000; (iv) $312,000 as against Mr.
Dietrich; (v) an award for reasonable legal fees and costs of litigation; (vi) a
judgment awarding specific performance under the Power Up Notes; and (vii) the
costs and disbursement of the action, pre-judgment interest, default interest
and such other further relief as the court deems proper.



NOTE 9 - CONVERTIBLE NOTES PAYABLE





On July 5, 2018, the Company issued secured convertible notes to certain
accredited investors in the aggregate principal amount of $1,650,000. The notes
matured on January 5, 2019 and accrued no interest. Net proceeds received by the
Company were $1,492,500 after deduction of legal and other fees. During 2019,
the remaining principal amount of $390,000 and accrued interest of $22,831 were
converted into shares of the Company's common stock.



In connection with the issuance of the July 2018 notes, the Company and the
investors also entered into a security agreement pursuant to which the notes are
secured by all of the assets of the Company held as of July 5, 2018 and acquired
thereafter. The Company also issued five-year warrants to purchase an aggregate
of 6,600,000 shares of Company's common stock with an initial exercise price of
$0.25. The warrants contain certain anti-dilutive provisions.



                                      -11-





On December 17, 2018, the Company issued a secured convertible promissory note
in the principal amount of $2,225,000 (including an original issuance discount
of $225,000) that matured on December 17, 2019 and bears interest at a rate of
8% per annum (which increased to 22% on July 16, 2019 upon the occurrence of an
event of default). The note is secured by the Security Agreement (as defined
below). The noteholder shall have the right to convert the Outstanding Balance
(as defined in the note) of the note at any time into shares of common stock of
the Company at a conversion price of $0.35 per share, subject to adjustment.
Commencing on June 17, 2019, the investor shall have the right to redeem all or
any portion of the note; provided, however, the investor may not request
redemption in an amount that exceeds $350,000 during any single calendar month;
provided, further however, upon the occurrence of an event of default, the
redemption amount in any calendar month may exceed $350,000. Payments on
redemption amounts may be made in cash, by converting the redemption amount into
shares of the Company's common stock at a conversion price of the lesser of: (a)
$0.35 per share, subject to adjustment; and (b) the Market Price (as defined in
the note), or a combination thereof. Upon the occurrence of an event of default,
the investor may accelerate the note pursuant to which the Outstanding Balance
will become immediately due and payable in cash at the Mandatory Default Amount
(as defined in the note). The Company is prohibited from effecting a conversion
of the note to the extent that, as a result of such conversion, the investor,
together with its affiliates, would beneficially own more than 4.99% of the
number of shares of the Company's common stock outstanding immediately after
giving effect to the issuance of shares of common stock upon conversion of the
note, which beneficial ownership limitation may be increased by the investor up
to, but not exceeding, 9.99%.



In connection with the December 2018 note, the Company also entered into a
security agreement (the "Security Agreement") on the closing date pursuant to
which the Company granted the investor a security interest in the Collateral (as
defined in the Security Agreement). On July 16, 2019, the Company received a
notice from an investor indicating that events of default had occurred and
asserting default penalties of $761,330. During the year ended December 31,
2019, the noteholder converted $345,000 of principal into an aggregate of
53,522,295 shares of common stock. During the three months ended March 31, 2020,
the holder converted $22,000 of principal into an aggregate of 12,359,551 shares
of common stock. As of March 31, 2020 and December 31, 2019, the remaining
carrying value of the note was $1,858,000 and $1,880,000, respectively, net of
debt discount of $0. As of March 31, 2020 and December 31, 2019, accrued
interest payable of $1,438,306 and $1,327,110, respectively, was outstanding on
the note.



From January to June 2019, the Company issued convertible promissory notes in
the aggregate principal amount of $389,000 (including aggregate original
issuance discount of $39,000) maturing at dates ranging from July 15, 2019 to
June 6, 2020 and accruing interest at rates ranging from 5% to 12% per annum.
The Company shall have the right to prepay the notes for an amount equal to 130%
multiplied by the portion of the Outstanding Balance (as defined in the notes)
being prepaid. The investors shall have the right to convert the Outstanding
Balance of the notes at any time into shares of common stock of the Company at a
conversion price of $0.075 per share, subject to adjustment. Upon maturity,
payment may be made in cash, by converting the redemption amount into shares of
the Company's common stock at a conversion price of the lesser of: (a) $0.075
per share, subject to adjustment; and (b) the Market Price (as defined in the
notes), or a combination thereof. Upon the occurrence of an event of default,
the investors may accelerate the note pursuant to which the Outstanding Balance
will become immediately due and payable in cash at the Mandatory Default Amount
(as defined in the notes). The Company is prohibited from effecting a conversion
of any note to the extent that, as a result of such conversion, the investor,
together with its affiliates, would beneficially own more than 4.99% of the
number of shares of the Company's common stock outstanding immediately after
giving effect to the issuance of shares of common stock upon conversion of the
note, which beneficial ownership limitation may be increased by the investor up
to, but not exceeding, 9.99%. In January 2020, one of the promissory notes was
amended whereby the conversion price for $9,202 which is a portion of the
principal amount of the note was amended to $0.0004 per share. The amendment was
deemed a debt modification and accounted for accordingly. During the year ended
December 31, 2019, the holders of the convertible promissory notes converted
$31,180 of principal and $8,000 of accrued interest into an aggregate of
10,000,000 shares of common stock. During the three months ended March 31, 2020,
one of the noteholders converted $24,826 of principal into an aggregate of
35,005,850 shares of common stock. As of March 31, 2020 and December 31, 2019,
the remaining carrying value of the notes was $277,297 and $247,746, net of debt
discount of $55,697 and $110,074, respectively. As of March 31, 2020 and
December 31, 2019, accrued interest payable of $550,256 and $456,900,
respectively, was outstanding on the notes.



                                      -12-





On November 13, 2019, the Company issued convertible promissory notes in the
aggregate principal amount of $108,900, having an aggregate original issuance
discount of $9,900, resulting in cash proceeds of $99,000. The notes mature May
13, 2020 and accrue interest at a rate of 12% per annum. During the first 180
days the notes are outstanding, the Company shall have the right to prepay the
notes for an amount equal to 120% (during the first 90 days) or 135% (during the
subsequent 90 days) of the Outstanding Balance (as defined in the notes) being
prepaid. The investors shall have the right to convert the Outstanding Balance
of the notes at any time into shares of common stock of the Company at a
conversion price of $0.01 per share, subject to adjustment. In the event of
default, the conversion price shall be 60% of the average of the three lowest
closing bid prices of the Company's common stock during the 20 days prior to the
conversion date. The Company is prohibited from effecting a conversion of any
note to the extent that, as a result of such conversion, the investor, together
with its affiliates, would beneficially own more than 4.99% of the number of
shares of the Company's common stock outstanding immediately after giving effect
to the issuance of shares of common stock upon conversion of the note, which
beneficial ownership limitation may be increased if the Market Capitalization
falls below $2,500,000, but not exceeding, 9.99%. As of March 31, 2020 and
December 31, 2019, the remaining carrying value of the notes was $57,680 and
$14,871, net of debt discount of $51,220 and $94,029, respectively. As of March
31, 2020 and December 31, 2019, accrued interest payable of $79,347 and $48,789,
respectively, was outstanding on the notes.



On December 6, 2019, the Company issued convertible promissory notes in the
aggregate principal amount of $110,000, having an aggregate original issuance
discount of $10,000, resulting in cash proceeds of $100,000. The notes mature
June 6, 2020 and accrue interest at a rate of 12% per annum. During the first
180 days the notes are outstanding, the Company shall have the right to prepay
the notes for an amount equal to 120% (during the first 90 days) or 135% (during
the subsequent 90 days) of the Outstanding Balance (as defined in the notes)
being prepaid. The investors shall have the right to convert the Outstanding
Balance of the notes at any time into shares of common stock of the Company at a
conversion price of $0.01 per share, subject to adjustment. In the event of
default, the conversion price shall be 60% of the average of the three lowest
closing bid prices of the Company's common stock during the 20 days prior to the
conversion date. The Company is prohibited from effecting a conversion of any
note to the extent that, as a result of such conversion, the investor, together
with its affiliates, would beneficially own more than 4.99% of the number of
shares of the Company's common stock outstanding immediately after giving effect
to the issuance of shares of common stock upon conversion of the note, which
beneficial ownership limitation may be increased if the Market Capitalization
(as defined in the notes) falls below $2,500,000, but not exceeding, 9.99%. As
of March 31, 2020 and December 31, 2019, the remaining carrying value of the
notes was $69,727 and $15,027, net of debt discount of $40,273 and $94,973,
respectively. As of March 31, 2020 and December 31, 2019, accrued interest
payable of $60,395 and $38,904, respectively, was outstanding on the notes.



In December 2019, the Company and the holders of all of the outstanding Series A
and Series B Preferred Shares (the "Preferred Shares") entered into Exchange
Agreements whereby 2,800 Series A Preferred Shares and 1,126 Series B Preferred
Shares were cancelled in exchange for the issuance of an aggregate of $3,500,000
and $1,548,250 of convertible promissory notes, respectively. The notes have
maturity dates ranging from December 24, 2019 through May 18, 2020 and accrue
interest at a rate of 12% per annum. During the first 180 days the notes are
outstanding, the Company shall have the right to prepay the notes for an amount
equal to 120% (during the first 90 days) or 135% (during the subsequent 90 days)
of the Outstanding Balance (as defined in the notes) being prepaid. The
investors shall have the right to convert the Outstanding Balance of the notes
at any time into shares of common stock of the Company at a conversion price of
$0.005 per share, subject to adjustment. In the event of default, the
Outstanding Balance shall immediately increase to 130% of the Outstanding
Balance and a penalty of $100 per day shall accrue until the default is
remedied. For a period of two years from the issuance date, in the event the
Company issues or sells any additional common shares or common stock equivalents
at a price less than the Conversion Price (as defined in the notes) then in
effect (a "Dilutive Issuance"), the Conversion Price of the notes shall be
reduced to the Dilutive Issuance Price and the number of shares issuable upon
conversion shall be increased on a full ratchet basis. The Company is prohibited
from effecting a conversion of any note to the extent that, as a result of such
conversion, the investor, together with its affiliates, would beneficially own
more than 9.99% of the number of shares of the Company's common stock
outstanding immediately after giving effect to the issuance of shares of common
stock upon conversion of the note.  During the year ended December 31, 2019, the
noteholders converted $185,500 of principal and $300 of accrued interest into an
aggregate of 30,669,903 shares of common stock and 37,160,000 shares of common
stock to be issued. During the three months ended March 31, 2020, the
noteholders converted $31,137 of principal and $128 of accrued interest into an
aggregate of 6,253,056 shares of common stock. As of March 31, 2020 and December
31, 2019, the remaining carrying value of the notes was $4,811,386 and
$4,781,395, net of debt discount of $20,226 and $81,355, respectively. As of
March 31, 2020 and December 31, 2019, accrued interest payable of $1,846,673 and
$1,583,795, respectively, was outstanding on the notes.



                                      -13-





From January and March 2020, the Company issued convertible promissory notes in
the aggregate principal amount of $145,200, having an aggregate original
issuance discount of $13,200, resulting in cash proceeds of $132,000. The notes
mature during July and September 2020 and accrue interest at a rate of 12% per
annum. During the first 180 days the notes are outstanding, the Company shall
have the right to prepay the notes for an amount equal to 120% (during the first
90 days) or 135% (during the subsequent 90 days) of the Outstanding Balance (as
defined in the notes) being prepaid. The investors shall have the right to
convert the Outstanding Balance of the notes at any time into shares of common
stock of the Company at a conversion price of $0.01 per share, subject to
adjustment. In the event of default, the conversion price shall be 60% of the
average of the three lowest closing bid prices of the Company's common stock
during the 20 days prior to the conversion date. The Company is prohibited from
effecting a conversion of any note to the extent that, as a result of such
conversion, the investor, together with its affiliates, would beneficially own
more than 4.99% of the number of shares of the Company's common stock
outstanding immediately after giving effect to the issuance of shares of common
stock upon conversion of the note, which beneficial ownership limitation may be
increased if the Market Capitalization (as defined in the notes) falls below
$2,500,000, but not exceeding, 9.99%. As of March 31, 2020, the remaining
carrying value of the notes was $58,153, net of debt discount of $87,047. As of
March 31, 2020, accrued interest payable of $58,180 was outstanding on the
notes.



Upon the issuance of certain convertible notes, the Company determined that the
features associated with the embedded conversion option embedded in the notes,
should be accounted for at fair value, as a derivative liability, as the Company
cannot determine if a sufficient number of shares would be available to settle
all potential future conversion transactions.



The Company does not have enough authorized and unissued common shares to
convert all of the convertible promissory notes into common shares. As a result
of this authorized shares shortfall, all of the convertible notes payable,
including those where the maturity date has not yet been reached, are in
default. Accordingly, (i) interest has been accrued at the default interest
rate, if applicable, and (ii) the embedded conversion option has been accounted
for, at fair value, as a derivative liability (See Note 10).



NOTE 10 - DERIVATIVE LIABILITIES AND FAIR VALUE MEASUREMENTS





The Company does not have enough authorized and unissued common shares to
convert all of its outstanding convertible promissory notes into common shares.
As a result of this authorized shares shortfall, the embedded conversion feature
in all of the Company's outstanding convertible notes payable and convertible
preferred shares as well as the Company's outstanding warrants have been
accounted for as derivative liabilities, at fair value, as the Company cannot
determine if a sufficient number of shares would be available to settle all
potential future conversion transactions.



During the three months ended March 31, 2020, upon issuance of the instruments
underlying the derivative liabilities and upon revaluation (immediately prior to
conversion), the Company estimated the fair value of the embedded derivatives
using the Black-Scholes Pricing Model based on the following assumptions: (1)
dividend yield of 0%, (2) expected volatility of 119.51% to 122.40%, (3)
risk-free interest rate of 0.24% to 1.56%, and (4) expected life of 0.5 years.



On March 31, 2020, the Company estimated the fair value of the embedded
derivatives of $50,898,006 using the Black-Scholes Pricing Model based on the
following assumptions: (1) dividend yield of 0%, (2) expected volatility of
122.48%, (3) risk-free interest rate of 0.05% to 0.29%, and (4) expected life of
0.02 to 2.84 years.



During the year ended December 31, 2019, upon issuance of the instruments
underlying the derivative liabilities and upon revaluation (immediately prior to
conversion), the Company estimated the fair value of the embedded derivatives
using the Black-Scholes Pricing Model based on the following assumptions: (1)
dividend yield of 0%, (2) expected volatility of 110.59% to 119.18%, (3)
risk-free interest rate of 1.48% to 2.33%, and (4) expected life of 0.01 to

3.0
years.



On December 31, 2019, the Company estimated the fair value of the embedded
derivatives of $20,236,870 using the Black-Scholes Pricing Model based on the
following assumptions: (1) dividend yield of 0%, (2) expected volatility of
119.18%, (3) risk-free interest rate of 1.48% to 1.62%, and (4) expected life of
0.01 to 3.09 years.



                                      -14-





ASC 820 establishes a fair value hierarchy that requires an entity to maximize
the use of observable inputs and minimize the use of unobservable inputs when
measuring fair value. An asset's or liability's categorization within the fair
value hierarchy is based upon the lowest level of input that is significant to
the fair value measurement. ASC 820 establishes three levels of inputs that may
be used to measure fair value:



? Level 1 - Quoted prices in active markets for identical assets or liabilities.

? Level 2 - Observable inputs other than Level 1 prices such as quoted prices for

similar assets or liabilities; quoted prices in markets with insufficient

volume or infrequent transactions (less active markets); or model-derived

valuations in which all significant inputs are observable or can be derived

principally from or corroborated by observable market data for substantially

the full term of the assets or liabilities.

? Level 3 - Unobservable inputs to the valuation methodology that are significant


   to the measurement of fair value of assets or liabilities.



All items required to be recorded or measured on a recurring basis are based upon Level 3 inputs.





To the extent that valuation is based on models or inputs that are less
observable or unobservable in the market, the determination of fair value
requires more judgment. In certain cases, the inputs used to measure fair value
may fall into different levels of the fair value hierarchy. In such cases, for
disclosure purposes, the level in the fair value hierarchy within which the fair
value measurement is disclosed and is determined based on the lowest level input
that is significant to the fair value measurement.



The Company recognizes its derivative liabilities as Level 3 and values its
derivatives using the methods discussed below. While the Company believes that
its valuation methods are appropriate and consistent with other market
participants, it recognizes that the use of different methodologies or
assumptions to determine the fair value of certain financial instruments could
result in a different estimate of fair value at the reporting date. The primary
assumptions that would significantly affect the fair values using the methods
discussed are that of volatility and market price of the underlying common

stock
of the Company.


At March 31, 2020 and December 31, 2019, the Company did not have any derivative instruments that were designated as hedges.

Items recorded or measured at fair value on a recurring basis in the accompanying condensed consolidated financial statements consisted of the following items as of March 31, 2020 and December 31, 2019:





                                                              Quoted Prices         Significant
                                                                in Active              Other           Significant
                                                               Markets for          Observable         Unobservable
                                            March 31,        Identical Assets         Inputs              Inputs
                                               2020             (Level 1)            (Level 2)           (Level 3)
Derivative liabilities                     $ 50,898,006     $                -     $            -     $    50,898,006



                                                               Quoted Prices         Significant
                                                                 in Active              Other          Significant
                                                                Markets for          Observable        Unobservable
                                           December 31,       Identical Assets         Inputs             Inputs
                                               2019              (Level 1)            (Level 2)          (Level 3)
Derivative liabilities                     $  20,236,870     $                -     $            -     $  20,236,870



                                      -15-




The following table provides a summary of changes in fair value of the Company's Level 3 financial liabilities for the three months ended March 31, 2020:


Balance, December 31, 2019                                               $

20,236,870

Transfers in due to issuance of convertible notes and warrants with embedded conversion and reset provisions

103,255

Transfers out due to conversions of convertible notes and accrued interest into common shares

                                                  (244,152 )
Derivative liability due to authorized shares shortfall                   

31,129,095


Mark to market to March 31, 2020                                             (327,062 )
Balance, March 31, 2020                                                  $

50,898,006



Gain on change in derivative liabilities for the three months ended
March 31, 2020                                                           $    327,062




Fluctuations in the Company's stock price are a primary driver for the changes
in the derivative valuations during each reporting period. As the stock price
increases/(decreases) for each of the related derivative instruments, the value
to the holder of the instrument generally increases/(decreases), therefore
increasing/(decreasing) the liability on the Company's balance sheet. Decreases
in the conversion price of the Company's convertible notes are another driver
for the changes in the derivative valuations during each reporting period. As
the conversion price decreases for each of the related derivative instruments,
the value to the holder of the instrument (especially those with full ratchet
price protection) generally increases, therefore increasing the liability on the
Company's balance sheet. Additionally, stock price volatility is one of the
significant unobservable inputs used in the fair value measurement of each of
the Company's derivative instruments. The simulated fair value of these
liabilities is sensitive to changes in the Company's expected volatility.
Increases in expected volatility would generally result in higher fair value
measurements. A 10% change in pricing inputs and changes in volatilities and
correlation factors would not result in a material change in our Level 3 fair
value.


NOTE 11 - STOCKHOLDERS' DEFICIT





Preferred Stock


The Company is authorized to issue 10,000,000 shares of blank check preferred stock, par value $0.001 per share.





On July 2, 2019, the Company authorized the issuance of 6,000 Series A preferred
stock, par value $0.001 per share. The Series A preferred stock have a $1,250
stated value and are convertible into shares of common stock at $0.05 per share,
subject to certain adjustments. The Certificate of Designation for the Series A
preferred stock was filed on July 9, 2019.



As of March 31, 2020 and December 31, 2019, there were 0 shares of Series A Preferred Stock outstanding.





On June 24, 2019, the Company authorized the issuance of 2,000 shares of Series
B Preferred Stock, par value $0.001 per share. The Series B Preferred Stock have
a $1,250 stated value and are convertible into shares of common stock at $0.05
per share, subjected to certain adjustments. The Certificate of Designation for
the Series B Preferred Stock was filed on July 9, 2019.



As of March 31, 2020 and December 31, 2019, there were 0 shares of Series B Preferred Stock outstanding.





On July 16, 2019, the Company authorized the issuance of 1,000 Series C
Preferred Stock, par value $0.001 per share. The 1,000 Series C preferred shares
automatically convert into an aggregate of 1,000,000 shares of common stock upon
the Company listing on a national exchange or upon a Change in Control (as
defined in the Series C Certificate of Designation). The Certificate of
Designation for the Series C Preferred Stock was filed on July 19, 2019.



As of March 31, 2020 and December 31, 2019, there were 1,000 shares of Series C Preferred Stock outstanding.





Common Stock


The Company is authorized to issue 500,000,000 shares of common stock, par value $0.001 per share. As of March 31, 2020 and December 31, 2019, there were 474,976,405 and 384,266,948 shares of common stock issued and outstanding, respectively.

The following common stock transactions were recorded during the three months ended March 31, 2020:

On January 8, 2020, the Company issued 37,160,000 shares of the Company's common stock previously recorded as to be issued as of December 31, 2019.

On March 7, 2020, a stockholder contributed 69,000 shares of the Company's common stock back to the Company. The shares were immediately retired. Accordingly, common stock was decreased by the par value of the common shares contributed of $69 with a corresponding increase in additional paid in capital.





                                      -16-





During the three months ended March 31, 2020, the Company issued an aggregate of
53,618,457 shares of its common stock, having an aggregate fair value of
$320,130, upon the conversion of convertible notes with a principal amount of
$77,964 and accrued interest of $128, which resulted in the elimination of
$244,152 of derivative liabilities and an aggregate gain on conversion of
convertible notes of $2,114. Accordingly, common stock was increased by the par
value of the common shares issued of $53,619 and additional paid in capital

was
increased by $266,511.



NOTE 12 - WARRANTS


Warrants outstanding and exercisable at March 31, 2019 are as follows:





                     Warrants          Weighted Avg.           Warrants
Exercise Price     Outstanding         Remaining Life        Exercisable
$0.0001 - 0.25     17,161,137,274                 2.71       17,161,137,274
0.26 - 0.50               465,002                 1.44              465,002
0.51 - 0.75                50,000                 0.02               50,000
0.76 - 1.00               275,000                 0.50              275,000
                   17,161,927,276                 2.71       17,161,927,276




A summary of the warrant activity for the three months ended March 31, 2020 is
as follows:



                                                                                 Weighted-
                                                                Weighted-         Average
                                                                 Average         Remaining        Aggregate
                                                                 Exercise       Contractual       Intrinsic
                                                Shares            Price            Term             Value

Outstanding at January 1, 2020                3,342,376,365     $  0.00265              2.96     $  8,791,956
Grants                                       13,819,650,911        0.00040
Exercised                                                 -              -
Expired/Cancelled                                  (100,000 )      0.50000
Outstanding at March 31, 2020                17,161,927,276     $  0.00051              2.71     $ 22,294,918
Exercisable at March 31, 2020                17,161,927,276     $  0.00051
            2.71     $ 22,294,218




The aggregate intrinsic value of outstanding stock warrants was $22,294,218,
based on warrants with an exercise price less than the Company's stock price of
$0.0017 as of March 31, 2020, which would have been received by the warrant
holders had those holders exercised the warrants as of that date.



NOTE 13 - STOCK OPTIONS



Our stockholders approved our 2014 Equity Incentive Plan in June 2014 (the "2014
Plan"), our 2015 Equity Incentive Plan in December 2015 (the "2015 Plan"), our
2016 Equity Incentive Plan in October 2016 ("2016 Plan"), our 2017 Equity
Incentive Plan in December 2016 ("2017 Plan" and together with the 2014 Plan,
2015 Plan, 2016 Plan, the "Prior Plans") and our 2018 Equity Incentive Plan in
June 2018 (the "2018 Plan", and together with the Prior Plans, the "Plans"). The
Prior Plans are identical, except for the number of shares reserved for issuance
under each. As of March 31, 2020, the Company had granted an aggregate of
64,310,000 securities under the Plans, with 190,000 shares available for future
issuances.



The Plans provide for the grant of incentive stock options to our employees and
our subsidiaries' employees, and for the grant of stock options, stock bonus
awards, restricted stock awards, performance stock awards and other forms of
stock compensation to our employees, including officers, consultants and
directors. The Prior Plans also provide that the grant of performance stock
awards may be paid out in cash as determined by the committee administering

the
Prior Plans.



                                      -17-





Stock options outstanding and exercisable as of March 31, 2020 are as follows:



                  Number of        Remaining Life       Number of Options
Exercise Price     Options            In Years             Exercisable
$0.01 - 0.25       13,306,786                 8.01              13,306,786
0.26 - 0.50         1,939,631                 7.01               1,939,631
0.51 - 0.75         1,820,112                 6.43               1,820,112
0.76 - 1.00         9,926,072                 6.46               9,926,072
1.01 - 2.00           629,164                 6.36                 629,164
                   27,621,765                                   27,621,765




A summary of the stock option activity for the three months ended March 31, 2020
is as follows:



                                                                              Weighted-
                                                             Weighted-         Average
                                                              Average         Remaining         Aggregate
                                                             Exercise        Contractual        Intrinsic
                                              Shares           Price            Term              Value

Outstanding at January 1, 2020               27,621,765     $      0.49              7.49     $           -
Grants                                                -
Exercised                                             -
Expired/Cancelled                                     -
Outstanding at March 31, 2020                27,621,765     $      0.49              7.24     $           -
Exercisable at March 31, 2020                27,621,765     $      0.49
         7.24     $           -



The aggregate intrinsic value of outstanding stock options was $0, based on options with an exercise price less than the Company's stock price of $0.0017 as of March 31, 2020, which would have been received by the option holders had those option holders exercised their options as of that date.


Option valuation models require the input of highly subjective assumptions. The
fair value of stock-based payment awards was estimated using the Black-Scholes
option pricing model with a volatility figure derived from historical data. The
Company accounts for the expected life of options based on the contractual life
of options for non-employees.



The fair value of all options that vested during the three months ended of March
31, 2020 and 2019 were $0 and $14,000, respectively. Unrecognized compensation
expense of $0 at March 31, 2020 will be expensed in future periods.



NOTE 14 - SUBSEQUENT EVENTS


The Company evaluates events that have occurred after the balance sheet date but before the condensed consolidated financial statements are issued.

On April 17, 2020, the Company issued convertible notes in the aggregate principal amount of $330,000 (including an aggregate of $30,000 original issuance discount) which notes accrue interest at a rate of 12% per annum and maturing on October 17, 2020.





On May 3, 2020, the Company received a loan in the principal amount of $50,000
pursuant to the Paycheck Protection Program ("PPP") of the Coronavirus Aid,
Relief, and Economic Security Act. The PPP loan matures in May 2022 and accrues
interest at the rate of 1% per annum. Payments of principal and interest of any
unforgiven balance commence in December 2020.



On May 13, 2020, the Company issued an aggregate of 18,750,000 shares of common stock upon the conversion of $15,000 in principal amount of convertible notes.

On June 26, 2020, the Company issued a note in the principal amount of $60,000. The secured promissory note accrues interest at a rate of 10% per annum and matures on June 26, 2022.





On July 8, 2020, the Company issued a promissory note in the principal amount of
$22,911 which note accrues interest at a rate of 10% per annum and matures

on
December 31, 2020.


On July 13, 2020, the Company issued convertible notes in the aggregate principal amount of $110,000 (including an aggregate of $10,000 original issuance discount) which notes accrue interest at a rate of 12% per annum and mature on January 13, 2021.





On August 31, 2020 and September 1, 2020, the Company issued convertible notes
in the aggregate principal amount of $115,500 (including an aggregate of $10,500
original issuance discount) which notes accrue interest at a rate of 12% per
annum and mature on March 1, 2021.



                                      -18-




ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS





You should read the following discussion and analysis in conjunction with our
condensed consolidated financial statements and related notes contained in Part
I, Item 1 of this Quarterly Report. Please also refer to the note about
forward-looking information for information on such statements contained in this
Quarterly Report immediately preceding Part I, Item 1.



COVID-19 Pandemic



On January 30, 2020, the World Health Organization ("WHO") announced a global
health emergency because of a new strain of coronavirus, COVID-19 originating in
Wuhan, China (and the risks to the international community as the virus spread
globally beyond its point of origin). In March 2020, the WHO classified the
COVID-19 outbreak as a pandemic, based on the rapid increase in exposure
globally.



The full impact of the COVID-19 outbreak continues to evolve as of the date of
this Quarterly Report on Form 10-Q. As such, it is uncertain as to the full
magnitude that the pandemic will have on the Company's financial condition,
liquidity, and future results of operations. Management is actively monitoring
the global situation and its impact on the Company's financial condition,
liquidity, operations, customers, industry, and workforce. Given the daily
evolution of the COVID-19 outbreak and the global responses to curb its spread,
the Company is not able to estimate the effects that the COVID-19 outbreak will
have on its results of operations, financial condition, or liquidity for fiscal
year 2020.



As of the date of this Quarterly Report on Form 10-Q, the Company has
experienced delays in securing new customers and related revenues and the longer
this pandemic continues there may be additional impacts. Furthermore, the
COVID-19 outbreak has and may continue to impact the Company's ability to raise
capital.



Although the Company cannot estimate the length or gravity of the impact of the
COVID-19 outbreak at this time, if the pandemic continues, it may have a
material adverse effect on the Company's results of future operations, financial
position, liquidity, and capital resources, and those of the third parties on
which the Company relies in fiscal year 2020.



Overview


MassRoots, Inc. was formed in April 2013 and over the past seven years has
partnered with numerous cannabis-related brands to advertise products to its
broad following across its website, MassRoots.com, and social media accounts.
Management believes that our YouTube Channel has one of the largest followings
in the regulated cannabis industry with more than 265,000 subscribers while our
Instagram account is followed by 387,000 users. Additionally, MassRoots has
920,000 opt-in email subscribers, 172,500 followers on our verified Twitter
account, and more than 200,000 monthly visitors to its website.



For much of our history, MassRoots has focused on building a technology platform for the cannabis industry. As part of our marketing strategy, we garnered a significant following across web, social media, and email channels that was highly successful at driving users to our platform.




While our long-term goal remains building a technology platform for the cannabis
industry, we believe it will likely take significant capital to do so.
Therefore, we believe it is in the best interests of our shareholders to focus
on monetizing our existing media channels over the coming months with the goal
of generating positive cash-flows from operations.



We are focused on monetizing our audience through product placements, display ads, and daily deals.





Competitors


We compete with other cannabis platforms such as WeedMaps and Leafly, which provide news and other information related to the cannabis industry. We believe our primary competitive advantage is the community and audience we have established, along with the data we have cultivated on key cannabis markets.





                                      -19-




For the three months ended March 31, 2020 and 2019





                                                               For the three months ended
                                              March 31,         March 31,
                                                 2020              2019            $ Change        % Change
Revenue                                     $            -     $      4,383     $       (4,383 )        (100 )%

Operating expenses                                 211,328          968,498           (757,170 )       (78.2 )%

Loss from Operations                              (211,328 )       (964,115 )          752,787         (78.1 )%

Other Income /(Expense)                        (31,741,568 )       (532,384

) (31,209,184 ) 5,862.2 %

Net Loss available to Common Stockholders $ (126,955,829 ) $ (1,496,499 ) $ (125,459,330 ) 8,383.5 %






Revenues


For the three months ended March 31, 2020 and 2019, we generated revenues of $0 and $4,383, respectively, a decrease of $4,383 primarily due to service interruptions to both the Company's website and production of content.





Operating Expenses



For the three months ended March 31, 2020 and 2019, our operating expenses were
$211,328 and $968,498, respectively, a decrease of $757,170. This decrease was
attributable to a decrease in stock-based compensation of $187,200 from $187,200
for the three months ended March 31, 2019 to $0 for the same period in 2020.
There was a decrease in payroll and related expenses of $88,583 due to reduction
in the number of employees as payroll and related expenses decreased to $82,736
for the three months ended March 31, 2020 from $171,319 for same period in 2019.
Advertising expense decreased to $0 for the three months ended March 31, 2020
from $27,208 for the same period in 2019, a decrease of $27,208. For the three
months ended March 31, 2020 and 2019, the Company recorded amortization of
software costs of $0 and $12,850, respectively, a decrease of $12,850. This is
primarily a result of the Company not incurring any software development costs.
Other general and administrative expenses decreased by $437,799 from $566,391
for the three months ended March 31, 2019 to $128,592 for the three months ended
March 31, 2020. This reduction was attributable to lower overhead costs for
office expenses, legal fees, rent expense and contractor services for the three
months ended March 31, 2020 as compared to the same period in 2019.



During the three months ended March 31, 2020, we incurred losses of $211,328
from operations, as compared to losses of $964,115 during the same period in
2019, a difference of $752,787, for the reasons stated above.



Other Income (Expense)



For the three months ended March 31, 2020 and 2019, the Company recorded
interest expense of $941,649 and $238,787, respectively, primarily related to
Company's convertible notes. The Company recorded a $2,114 gain and $293,597
loss on the conversion of convertible notes payable for the three months ended
March 31, 2020 and 2019, respectively. For the three months ended March 31, 2020
and 2019, the Company recorded $327,062 and $0, respectively, of gain on change
in fair value of derivative liabilities. For the three months ended March 31,
2020 and 2019, the Company recorded $31,129,095 and $0, respectively, of changes
in the fair value of the derivative liability for the authorized shares
shortfall.



Net Loss Available to Common Stockholders

For the three months ended March 31, 2020 and 2019, we had net losses of $126,955,829 and $1,496,499, respectively, an increase of $125,459,330 for the reasons discussed above.

Liquidity and Capital Resources





Net cash used in operations for the three months ended March 31, 2020 and 2019
was $109,352 and $286,583, respectively. This $177,231 decrease was primarily
caused by a decrease in stock-based compensation (non-cash items), a decrease in
interest and amortization of debt discount, and a decrease in accounts payable
and accrued expenses.  Net cash used in operations for the three months ended
March 31, 2019 was primarily based on the utilization of $444,133 in cash to
reduce accounts payable and other liabilities and the loss for the three months
ended March 31, 2019 which was offset by the increase in stock-based
compensation (non-cash item).



                                      -20-




Net cash used in investing activities for the three months ended March 31, 2020 and 2019 was $0 and $32,500, respectively.


Net cash provided by financing activities for the three months ended March 31,
2020 and 2019 was $109,082 and $290,000, respectively. During the three months
ended March 31, 2020, these funds were derived mainly from proceeds related to
the issuance of convertible notes. During the three months ended March 31, 2019,
net cash provided by financing activities was derived from the issuance of
convertible notes and advances.



Capital Resources



As of March 31, 2020, the Company had cash of $850 and working capital deficit
(current liabilities in excess of current assets) of $68,501,692. During the
three months ended March 31, 2020, net cash used in operating activities was
$109,352. These conditions raise substantial doubt about our ability to continue
as a going concern for one year from the issuance of the condensed consolidated
financial statements. Our primary source of operating funds since inception has
been cash proceeds from the public and private placements of our securities,
including debt securities, and proceeds from the exercise of warrants and
options. We have experienced net losses and negative cash flows from operations
since inception and expect these conditions to continue for the foreseeable
future. For the foreseeable future, our ability to continue our operations is
dependent upon our ability to obtain additional capital through public or
private equity offerings, debt financings or other sources ; however, financing
may not be available to us on acceptable terms, or at all. Our failure to raise
capital as and when needed would have a negative impact on our financial
condition and our ability to pursue our business strategy and we may be forced
to curtail or cease operations.



Management's plans regarding these matters encompass the following actions: 1)
obtain funding from new and current investors to alleviate our working capital
deficiency; and 2) implement a plan to generate revenues. Our continued
existence is dependent upon our ability to translate our audience into revenues.
However, the outcome of our plans cannot be determined with any degree of
certainty.



Accordingly, the accompanying condensed consolidated financial statements have
been prepared in conformity with accounting principles generally accepted in the
United States of America, which contemplates continuation of the Company as a
going concern and the realization of assets and satisfaction of liabilities in
the normal course of business for one year from the date the condensed
consolidated financial statements are issued. The carrying amounts of assets and
liabilities presented in the condensed consolidated financial statements do not
necessarily purport to represent realizable or settlement values. The condensed
consolidated financial statements do not include any adjustments that might
result from the outcome of this uncertainty.



Off-Balance Sheet Arrangements

As of March 31, 2020, we did not have any off-balance sheet arrangements.





Contractual Obligations



Our contractual obligations are included in our notes to the condensed
consolidated financial statements included in Part I, Item I of this Quarterly
Report on Form 10-Q. To the extent that funds generated from our operations,
together with our existing capital resources, are insufficient to meet future
requirements, we will be required to obtain additional funds through equity or
debt financings. No assurance can be given that any additional financing will be
made available to us or will be available on acceptable terms should such a

need
arise.


Critical Accounting Policies and Estimates





For a discussion of our accounting policies and related items, please see the
notes to the condensed consolidated financial statements, included in Part I,
Item 1 of this Quarterly Report on Form 10-Q.



                                      -21-

© Edgar Online, source Glimpses